Eagle Pharmaceuticals (EGRX) - News Mentions

Sign up to add (EGRX) to your portfolio and access more historical data.

00%
Est. daily news mentions.

Sign up to access historical data

Sign up

Similar companies

Company News Mentions
Amgen
Amgen
AMGN		 0 100%
Gilead Sciences
Gilead Sciences
GILD		 1 66.7%
Catalyst Pharmaceuticals
Catalyst Pharmaceuticals
CPRX		 0 0%
Inovio Pharmaceuticals
Inovio Pharmaceuticals
INO		 0 0%
Anavex Life Sciences
Anavex Life Sciences
AVXL		 0 0%
Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan
October 30
Eagle Pharmaceuticals Implements Stockholder Rights Plan
October 30
Union Square Park Capital Management, LLC Increases Stake in Eagle Pharmaceuticals Inc
October 30
StockNews.com Initiates Coverage on Eagle Pharmaceuticals (NASDAQ:EGRX)
October 29
Eagle Pharmaceuticals (NASDAQ:EGRX) Now Covered by StockNews.com
October 21
Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information
October 14
Union Square Park Capital Management's Strategic Acquisition of Eagle Pharmaceuticals Shares
October 8
Eagle Pharmaceuticals (NASDAQ:EGRX) Research Coverage Started at StockNews.com
October 3
Eagle Pharmaceuticals says in default under credit agreement
October 2
Eagle Pharmaceuticals sees 'one or more' material weaknesses
October 2
XTX Topco Ltd Buys New Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX)
October 2
Eagle Pharmaceuticals in Default Amid Delays in Financial Report Filings, Braces for Delisting
October 2
Eagle Pharmaceuticals Navigates Financial Uncertainty and Defaults
October 1
Eagle Pharmaceuticals commences review to evaluate range of alternatives
October 1
Eagle Pharmaceuticals delays annual report on Form 10-K filing
October 1
173,365 Shares in Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Bought by Perceptive Advisors LLC
September 30

How often is Eagle Pharmaceuticals mentioned in the news?

Eagle Pharmaceuticals was mentioned an estimated 0 times in online prominent news articles yesterday.

Analyzing News Mentions, how is Eagle Pharmaceuticals performing compared to its industry peers?

Eagle Pharmaceuticals underperforms its industry peers when it comes to News Mentions, ranking dead last.

Has there been an increase or decrease in news mentions of Eagle Pharmaceuticals in the last month?

There has been no significant change in the number of news mentions for Eagle Pharmaceuticals' compared to the last month.

Why is it important to track news mentions for Eagle Pharmaceuticals?

By monitoring mentions in the news for Eagle Pharmaceuticals, investors stay up to date on impactful events for the company, its industry and its competitors. Positive news might affect price in a positive way and negative news might affect price in a negative way. By tracking mentions over time, investors can also identify patterns, explore popularity and make informed decisions based on the evolving perception of Eagle Pharmaceuticals, ultimately improving their investment strategies.

Sign up and get more insights on Eagle Pharmaceuticals.

The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.



App download

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2024 AltIndex. All rights reserved.

Top Stocks

Trending Stocks
Trending Stocks on WallStreetBets
Trending Stocks on Reddit
Top Stocks
Top Stock Performers Today
Bottom Stock Performers Today
Best Airlines Stocks
Best Bank Stocks
Best Semiconductor Stocks
Best Energy Stocks
Best Fintech Stocks
Best Robotics Stocks
Best Insurance Stocks

Our Data

Datasets
Stock alerts
AI Stock Picks
AI Stock Picks - Results
Fear & Greed Index
Meme Stocks
Threads Users
Stock Predictor
Stock Picking Reviews
Stock Trading Signals
House & Congress Trading
Earnings Calendar
Index

AltIndex

News
Pricing
Sign up
Log in
API
Journalist Access
Data Disclaimer
Contact